IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — AGAE

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents10.444.2915.4523.0819.4910.9933.307.3010.4421.193.5984.2386.4590.7395.227.6910.54
Short-term Investments0.430.392.163.012.1066.7454.8069.6459.9554.5074.50------------
Accounts Receivable0.540.900.260.280.270.30--0.480.011.010.310.120.180.890.340.360.06
Total Current Assets52.0755.1083.0787.5398.01102.8194.7384.3376.4378.4380.4285.5687.1992.42101.5762.8963.51
Property, Plant & Equipment0.290.382.452.612.813.193.383.613.793.203.464.834.515.336.877.688.39
Goodwill1.332.252.872.852.8112.8612.4112.49------------------
Intangible Assets0.541.834.784.904.995.885.806.010.690.690.590.020.020.030.030.030.03
Total Non-current Assets*10.1412.9623.7021.0519.8527.0231.9632.6815.3214.6915.1910.299.9810.967.538.349.04
Total Assets62.2168.06106.77108.58117.86129.83126.70117.0291.7593.1295.6195.8597.16103.38109.1071.2372.55
Accounts Payable8.287.637.053.382.720.371.140.170.470.580.540.750.153.422.822.532.25
Short-term Debt--4.5010.8011.1010.90677.7010.001,300.00------------------
Total Current Liabilities30.8933.1046.4342.6540.7140.0432.9717.122.523.754.863.933.585.973.5240.3439.15
Total Non-current Liabilities*0.182.113.433.854.275.225.896.275.745.866.191.711.882.101.962.021.92
Total Liabilities31.0735.2149.8746.5044.9745.2638.8523.388.279.6111.055.635.468.075.4842.3541.07
Retained Earnings(168.88)(168.32)(145.35)(139.99)(135.18)(123.20)(119.17)(115.37)(112.75)(112.82)(112.13)(108.49)(106.85)(103.16)(94.25)(168.55)(165.61)
Total Stockholder Equity29.4929.8752.3857.5568.4174.0277.6683.3083.4883.5284.5690.2291.7095.31103.6228.8831.48

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue1.251.551.931.851.922.283.022.162.641.261.371.121.271.191.221.571.162.411.941.69
Research & Development0.040.210.150.170.170.180.340.160.17----------------------
Selling, General & Admin3.643.7912.387.186.025.483.951.315.242.861.910.892.222.542.012.402.623.453.533.20
Total Operating Expenses--------8.017.53----------------------------
Operating Income(2.27)(3.52)(20.38)(7.33)(6.09)(5.25)(14.16)(1.18)(5.29)(2.68)(1.91)(0.64)(1.40)(2.66)(2.70)(1.70)(3.62)(3.75)(2.78)(3.93)
Interest Expense-------------------------------------0.000.01
Pretax Income(1.94)(5.24)(20.03)(5.40)(4.83)(4.90)(12.93)(4.36)------------------------
Tax Provision------------(0.09)(0.33)------------------------
Net Income(0.56)(5.19)(17.78)(5.36)(4.81)(4.84)(7.23)(4.03)(3.80)(1.70)--0.08(0.69)(1.89)(1.74)(1.64)(3.69)(3.75)(5.16)74.30
Basic EPS(0.09)(0.83)(0.46)(0.14)(0.12)(0.11)(0.18)(0.11)(0.09)(0.04)(0.03)0.00(0.02)(0.05)------------
Diluted EPS(0.09)(0.83)(0.46)(0.14)(0.12)(0.11)(0.18)(0.11)(0.09)(0.04)(0.03)0.00(0.02)(0.05)------------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(2.36)(0.66)(6.10)(0.62)(0.89)(2.18)3.48(8.71)(2.39)(2.15)(3.54)(1.59)(1.98)(1.03)(2.38)(2.20)(4.22)(2.12)(2.23)(5.15)
Capital Expenditures----0.010.050.020.030.030.040.000.010.260.040.040.040.040.00(0.01)0.010.050.03
Free Cash Flow*----(6.11)(0.67)(0.91)(2.22)3.45(8.75)(2.40)(2.16)(3.80)(1.63)(2.02)(1.07)(2.42)(2.21)(4.22)(2.13)(2.28)(5.18)
Investing Cash Flow8.6311.382.64(6.94)11.00(45.09)48.58(26.45)16.18(14.49)0.21(8.99)20.01(5.10)(70.09)-0.000.01(0.05)(0.15)96.13
Financing Cash Flow0.00(18.40)(0.05)(0.10)(6.55)7.51(4.10)8.1812.227.639.20(0.18)(0.42)(1.46)--------0.00(3.42)

* Derived from reported values